METRONIDAZOLE IN PLASTIC CONTAINER Drug Patent Profile

When do Metronidazole In Plastic Container patents expire, and what generic alternatives are available?

Metronidazole In Plastic Container is a drug marketed by Baxter Hlthcare Corp, Gland Pharma Ltd, Hospira, Inforlife, and Rising. and is included in five NDAs.

The generic ingredient in METRONIDAZOLE IN PLASTIC CONTAINER is metronidazole. There are eighteen drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the metronidazole profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Metronidazole In Plastic Container

A generic version of METRONIDAZOLE IN PLASTIC CONTAINER was approved as metronidazole by TEVA PHARMS USA on November 6^th, 1984.

Summary for METRONIDAZOLE IN PLASTIC CONTAINER

US Patents:	0
Applicants:	5
NDAs:	5
Finished Product Suppliers / Packagers:	8
Raw Ingredient (Bulk) Api Vendors:	164
Clinical Trials:	499
Patent Applications:	4,192
Formulation / Manufacturing:	see details
DailyMed Link:	METRONIDAZOLE IN PLASTIC CONTAINER at DailyMed

Recent Clinical Trials for METRONIDAZOLE IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Tanta University	N/A
Pontificia Universidad Catolica de Chile	Phase 4
Assiut University	N/A

See all METRONIDAZOLE IN PLASTIC CONTAINER clinical trials

Pharmacology for METRONIDAZOLE IN PLASTIC CONTAINER

Drug Class

Nitroimidazole Antimicrobial

Anatomical Therapeutic Chemical (ATC) Classes for METRONIDAZOLE IN PLASTIC CONTAINER

A01AB	Antiinfectives and antiseptics for local oral treatment
A01A	STOMATOLOGICAL PREPARATIONS
A01	STOMATOLOGICAL PREPARATIONS
A	Alimentary tract and metabolism

D06BX	Other chemotherapeutics
D06B	CHEMOTHERAPEUTICS FOR TOPICAL USE
D06	ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
D	Dermatologicals

G01AF	Imidazole derivatives
G01A	ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
G01	GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
G	Genito-urinary system and sex hormones

J01XD	Imidazole derivatives
J01X	OTHER ANTIBACTERIALS
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

P01AB	Nitroimidazole derivatives
P01A	AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES
P01	ANTIPROTOZOALS
P	Antiparasitic products, insecticides and repellents

US Patents and Regulatory Information for METRONIDAZOLE IN PLASTIC CONTAINER

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare Corp	METRONIDAZOLE IN PLASTIC CONTAINER	metronidazole	INJECTABLE;INJECTION	078084-001	Mar 31, 2008	AP	RX	No	No
Inforlife	METRONIDAZOLE IN PLASTIC CONTAINER	metronidazole	INJECTABLE;INJECTION	206191-001	Feb 25, 2019	AP	RX	No	No
Gland Pharma Ltd	METRONIDAZOLE IN PLASTIC CONTAINER	metronidazole	INJECTABLE;INJECTION	212435-001	Aug 3, 2020	AP	RX	No	No
Hospira	METRONIDAZOLE IN PLASTIC CONTAINER	metronidazole	INJECTABLE;INJECTION	018890-002	Nov 18, 1983	AP	RX	Yes	Yes
Rising	METRONIDAZOLE IN PLASTIC CONTAINER	metronidazole	INJECTABLE;INJECTION	205531-001	May 9, 2017		DISCN	No	No